A Phase Ib/IIa Single Centre, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Dose Ranging Trial in Adult Participants With Uncomplicated Dengue Fever in Singapore

Trial Profile

A Phase Ib/IIa Single Centre, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Dose Ranging Trial in Adult Participants With Uncomplicated Dengue Fever in Singapore

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Modipafant (Primary) ; Celgosivir
  • Indications Dengue
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2017 Planned initiation date changed from 1 Jul 2017 to 1 Jul 2018.
    • 25 Apr 2017 Planned initiation date changed from 1 Jul 2016 to 1 Jul 2017.
    • 06 Oct 2015 Status changed from planning to not yet recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top